This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.
Otherwise, enjoy the column!
Subscribe to the Monster Stock Market Commentary to get the Daily Monster Market Commentary and join the 2,950 subscribers getting it for FREE!
Don’t forget to subscribe to get his report sent daily to your email for Free. It includes the sector scorecard and links to other great articles we write.
Biotech share, rose slightly today and we can see from the chart below, the ETF, has played a game of fill the gap. The gap was previously created back on July 19. The hourly chart shows that the ETF has now bottomed nicely and appears to be rounding higher.
Get our one-pager to learn more about Mott Capital
Technology stocks continue to trend higher as well, with a well defined regression channel. The trend line from the February. lows is still very much in tact.
Subscribe to the MCM Stock Market Commentary to get it Daily and join the 2,950 subscribers getting it for FREE!
We write research for institutions or individuals at reasonable rates. With reports starting at just $125. Find out more.
The S&P 500 continues to trace out along the February/Brexit lows, but the trend line continues to act as resistance. In fact, the recent setup in the triangle, tells us the index maybe getting to breakout shortly.
Disclaimer: Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendation made during the past twelve months. Past performance is not indicative of future performance.